The learned intermediary doctrine remains one of the most significant defenses asserted in medical device litigation. In general terms, manufacturers argue that their duty to warn runs to the prescribing or implanting physician, rather than directly to the patient.

Because prescription medical devices are intended for use under the supervision of licensed healthcare professionals, courts often focus on whether adequate warnings and instructions were provided to the treating clinician. If the warnings are deemed sufficient, manufacturers frequently argue that responsibility for patient counseling rests with the physician. See 21 C.F.R. § 801.109.

In practice, however, the doctrine is not absolute.

A central issue in many cases is whether the warnings provided to physicians were actually adequate. Device manufacturers are required to provide practitioner-directed labeling that fairly communicates material risks, contraindications, precautions, and safe-use information. Where warnings are incomplete, delayed, minimized, or inconsistent with internal company knowledge, the defense becomes more vulnerable.

Causation is equally important. In many cases, the outcome turns on testimony from the treating physician regarding whether different or additional warnings would have affected clinical decisions, patient counseling, monitoring, or device selection. Careful development of this testimony can be critical.

Direct-to-consumer marketing may also complicate the defense. Some courts have recognized limits to the doctrine where manufacturers heavily market devices directly to patients in ways that significantly influence patient demand or expectations. The New Jersey Supreme Court’s decision in Perez v. Wyeth Laboratories, Inc. remains one of the most widely discussed examples of this limitation.

From a plaintiff’s perspective, these cases often require close examination of what the physician actually received, when information became available, how risks were communicated internally within the company, and whether patients were exposed to promotional materials that minimized known concerns.

Medical device litigation involving the learned intermediary doctrine is highly fact-specific. While the defense can be powerful, it does not end the inquiry. Careful attention to the adequacy, timing, and real-world impact of warnings frequently determines whether the doctrine ultimately protects the manufacturer or leaves significant questions for the jury.